Trial · NCT00866749
Adverse events89
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 89
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Colitis | Gastrointestinal disorders | Augmented BFM Therapy | 6 | 120 | 6 |
| other | Rash | Skin and subcutaneous tissue disorders | Augmented BFM Therapy | 6 | 120 | 6 |
| other | Supraventricualr arrhythmia | Cardiac disorders | Augmented BFM Therapy | 6 | 120 | 7 |
| other | Hypoalbuminemia | Metabolism and nutrition disorders | Augmented BFM Therapy | 9 | 120 | 9 |
| other | Dehydration | Gastrointestinal disorders | Augmented BFM Therapy | 9 | 120 | 9 |
| other | Lipase | Metabolism and nutrition disorders | Augmented BFM Therapy | 9 | 120 | 9 |
| other | Mucositis | Gastrointestinal disorders | Augmented BFM Therapy | 22 | 120 | 26 |
| other | Constipation | Gastrointestinal disorders | Augmented BFM Therapy | 11 | 120 | 11 |
| other | Pain | General disorders | Augmented BFM Therapy | 29 | 120 | 38 |
| other | Osteoporosis | Musculoskeletal and connective tissue disorders | Augmented BFM Therapy | 11 | 120 | 12 |
| other | Pancreatitis | Gastrointestinal disorders | Augmented BFM Therapy | 11 | 120 | 12 |
| other | Osteonecrosis | Musculoskeletal and connective tissue disorders | Augmented BFM Therapy | 13 | 120 | 13 |
| other | Neutropenic Fever | Infections and infestations | Augmented BFM Therapy | 12 | 120 | 15 |
| other | Hypertriglyceridemia | Metabolism and nutrition disorders | Augmented BFM Therapy | 15 | 120 | 15 |
| other | Neuropathy motor | Nervous system disorders | Augmented BFM Therapy | 19 | 120 | 21 |
| other | Nausea | Gastrointestinal disorders | Augmented BFM Therapy | 19 | 120 | 23 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Augmented BFM Therapy | 22 | 120 | 24 |
| other | Neuropathy sensor | Nervous system disorders | Augmented BFM Therapy | 23 | 120 | 24 |
| other | Allergic reaction/hypersensitivity | Immune system disorders | Augmented BFM Therapy | 23 | 120 | 25 |
| other | Thrombosis | Vascular disorders | Augmented BFM Therapy | 22 | 120 | 29 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00866749/events